Exchange: NASDAQ Sector: Financial Services Industry: Shell Companies
-26.91% $6.03
America/New_York / 29 feb 2024 @ 15:59
FUNDAMENTALS | |
---|---|
MarketCap: | 31.09 mill |
EPS: | 0.150 |
P/E: | 40.20 |
Earnings Date: | Mar 30, 2023 |
SharesOutstanding: | 5.16 mill |
Avg Daily Volume: | 0.0262 mill |
RATING 2024-02-29 |
---|
A |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Sell | |
Return On Asset: | Buy | |
DE: | Neutral | |
P/E: | Strong Buy | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Ebit | ||||||
Asset | ||||||
Debt | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 40.20 | sector: PE -18.15 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE 40.20 | industry: PE -25.74 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 5.19 - 6.87 ( +/- 14.00%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-10-10 | Hindle-yang Fang | Sell | 76 142 | Common Stock |
2022-10-10 | Arisz Investment Llc | Sell | 76 142 | Common Stock |
2022-01-21 | Hindle-yang Fang | Sell | 128 206 | Common Stock |
2022-01-21 | Arisz Investment Llc | Sell | 128 206 | Common Stock |
2021-11-17 | Trivedi Rushi | Sell | 0 | Common Stock |
INSIDER POWER |
---|
-100.00 |
Last 22 transactions |
Buy: 1 764 445 | Sell: 408 696 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $6.03 (-26.91% ) |
Volume | 0.0689 mill |
Avg. Vol. | 0.0262 mill |
% of Avg. Vol | 262.90 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Arisz Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to pursue targets in the healthcare industry in North America, Europe, and Asia. The company was incorporated in 2021 and is based in New York, New York.